Buy Rossari Biotech, target price Rs 1095: Yes Securities
-
almost 2 years ago
In the longer run, under normalized operating conditions, the brokerage expects the operating margins to restore to 14-15% levels. In addition, Rossari continues to innovate, within its four core chemistries, developing products for new applications, across product segments.
Economic Times